Travere Therapeutics, Inc.
TVTX
DELAYED 1 MONTH

19 insider filings · Latest: May 19, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 15, 2026May 19 8:05 PMTimothy CoughlinDirector
Sale
3,250$43.49$141.3K52,250(D)

View →

May 5, 2026May 7 12:00 AMRoy D. BaynesDirector
Sale
4,500$46.65$209.9K37,500(D)

View →

May 4, 2026May 7 12:00 AMMeckler Jeffrey ADirector
Sale
8,000$45.00$360.0K87,500(D)

View →

May 6, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Sale
2,763$43.95$121.4K115,474(D)

View →

May 6, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Sale
2,076$43.95$91.2K105,211(D)

View →

May 5, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Sale
2,174$46.65$101.4K107,287(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Sale
20,000$45.00$900.0K105,211(D)

View →

May 6, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Sale
311$43.95$13.7K113,238(D)

View →

May 5, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Sale
2,174$46.65$101.4K113,549(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Sale
20,000$45.00$900.0K111,473(D)

View →

May 5, 2026May 7 12:00 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Sale
2,174$46.65$101.4K140,684(D)

View →

May 6, 2026May 7 12:00 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
22,500$43.95$988.9K432,886(D)

View →

May 6, 2026May 7 12:00 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
310$43.95$13.6K118,658(D)

View →

May 5, 2026May 7 12:00 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
2,181$46.65$101.7K118,968(D)

View →

May 1, 2026May 4 8:27 PMRoy D. BaynesDirector
Sale
9,750$44.22$431.1K37,500(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 19, 2026May 21 9:00 PMBrinkley Ruth WilliamsDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRon SquarerDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSandra PooleDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMJohn A OrwinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMMeckler Jeffrey ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMLYONS GARY ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMTimothy CoughlinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSuzanne Louise BruhnDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRoy D. BaynesDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 5, 2026May 7 12:00 AMRoy D. BaynesDirector
Option Exercise
4,500$18.270(D)

View →

May 4, 2026May 7 12:00 AMMeckler Jeffrey ADirector
Option Exercise
8,000$16.330(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Grant/Award
8,500—8,500(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Option Exercise
4,250—4,250(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Grant/Award
8,500—8,500(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
24,250$17.964,250(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Grant/Award
8,500—8,500(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Option Exercise
24,250$22.404,250(D)

View →

May 4, 2026May 7 12:00 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Grant/Award
8,500—8,500(D)

View →

May 4, 2026May 7 12:00 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Option Exercise
4,250—4,250(D)

View →

May 4, 2026May 7 12:00 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
22,500—22,500(D)

View →

Page 1 of 2

Next →